BioSpace News Archive

Pharm Country

Medidata Selected by ICON to Evolve Image Management and Accelerate Research Goals for Sponsors and Sites During Clinical Trials

ICON will expand its use of the Medidata Clinical Cloud to include image management services for end-to-end digital control of the healthcare industry’s fastest growing data source.

November 15, 2017

·

3 min read

Drug Development

Achillion Reports Preliminary Proof-of-Concept With ACH-4471 for the Treatment of C3G

Greater than 50% improvement in proteinuria (albumin to creatinine ratio) after 14 days of oral dosing with ACH-4471.

November 15, 2017

·

11 min read

Bedfont Scientific Release: Local, Second-Generation, Family Business Named as a Finalist In 3 Categories for its First Ever Regional Awards

Bedfont Scientific is up for 3 different awards categories in the MISE Awards.

November 15, 2017

·

1 min read

Capital Increase in Genmab as a Result of Employee Warrant Exercise

The company will increase its share capital by 22,532 shares as a consequence of the exercise of employee warrants.

November 15, 2017

·

4 min read

Business

Genmab Achieves $25M Milestone for First Commercial Sale of DARZALEX® (daratumumab) in Japan and Updates Financial Guidance

First commercial sale of DARZALEX in Japan triggers USD 25 million in milestone payments from Janssen.

November 15, 2017

·

8 min read

Pharm Country

Achillion Announces Proposed Secondary Offering of Common Stock

Achillion will not sell any shares or receive any proceeds from the offering, and the total number of shares of its outstanding common stock will not change as a result of the offering.

November 15, 2017

·

3 min read

Business

Asterias Biotherapeutics Reports Third Quarter Financial Results and Recent Developments

As of September 30, 2017, the combined total of cash, cash equivalents, and available-for-sale securities totaled $20.7 million.

November 15, 2017

·

11 min read

Business

aTyr Pharma Announces Third Quarter 2017 Operating Results and Provides Corporate Update

Research and development expenses were $7.1 million and $10.4 million for the three months ended September 30, 2017 and 2016, respectively. T

November 15, 2017

·

8 min read

Pharm Country

Amarin: Real World Data Analysis Shows That Persistent Hypertriglyceridemia Despite Statin Therapy is Associated With Cardiovascular Risk

This analysis of RWE is separate from and independent of the RWE analysis referenced in Amarin’s press release on November 12, 2017.

November 15, 2017

·

9 min read

Biotech Beach

Mirati Therapeutics Announces Proposed Public Offering of Common Stock

Mirati today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock. Mirati expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering.

November 15, 2017

·

4 min read